ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community
Sponsored by Sam Houston State University
About this study
The purpose of this project is to examine the feasibility/acceptability of a one-day Acceptance and Commitment Therapy + Lifestyle Education group intervention paired with 12-weeks of Continuous Glucose Monitoring for patients with type 2 diabetes (T2D) living in rural communities. This study is being designed as a randomized control trial (RCT) comparing ACT+LE+CGM to LE+CGM to LE. The ultimate goal of this line of research is that a community-wide intervention of Acceptance and Commitment Therapy (ACT) with Continuous Glucose Monitoring (CGM) and Lifestyle Education (LE) will improve T2D outcomes in rural communities compared to CGM and LE, or LE alone. Our goal is to develop a scalable and sustainable program for diabetes management in rural areas that enables individual self-management and does not require extensive healthcare resources in an existing medical desert.
ADA guidelines highlight the essential role of nutrition therapy and/or diabetes self-management education (DSME) programs in diabetes management. A recent NHANES analysis which included 2365 people with diabetes indicated that only 32% are considered in good control of diabetes (HbA1c 6.5-6.9%). In the rural community at higher risk of diabetes, conventional lifestyle intervention approaches to diabetes management (e.g., Look AHEAD) or prevention, are not sustainable as they are resource intense. In medical deserts such as rural areas, there is a need for alternative strategies. To add, a mechanism that can impact lack of behavioral adherence is experiential avoidance. Experiential avoidance describes avoiding or escaping behaviors that cause B. distress, anxiety, shame, guilt, pain, and …
Where this study is enrolling
- I'm interested
Sam Houston State University College of Osteopathic Medicine
Conroe, Texas
Who can participate
Inclusion criteria
- ✓1. Diagnosed diabetes (self-reported) and with an HbA1c ≥ 6.0 (using point-of-care device)
- ✓2. at least 18 years of age or older
- ✓3. able to speak English
- ✓4. able to provide informed consent and participate in the study
- ✓5. reliable access to a personal smartphone device 6) zip code is associated with a rural area.
Exclusion criteria
- ✕1. Reported suicidal ideation at the initial visit
- ✕2. has evidence of acute psychosis that precludes informed consent
- ✕3. appears to be cognitively impaired to the extent that precludes informed consent
- ✕4. uses a heavy amount of alcohol or other substances
- ✕5. is deemed by the multidisciplinary study team has too medically complex for a more conservative treatment approach
- ✕6. has a pacemaker or other implanted electrical medical device
- ✕7. Pregnant (management of diabetes while pregnant may require additional medical oversight).
- ✕8. Under 18 years old (protocol was validated for adults)
- ✕9. Non-English-speaking individuals (protocol has not been translated and validated in other languages)
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.